Shared by
beno
Fundamentals
N/a
Catalysts / News / Painting the picture
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
Technical Analysis
-Intraday pattern: Mountain
-Levels: 27.50, 29, 30, 31, 32.50
Original Plan / Strategy
First test short of 29 level with whole dollar confluence
Review
This was a good trade to take but it took much longer for the stock to pull back so I started stopping out from my lots slowly when I noticed lots of buying above 29. I missed the real move down of course...
Lessons Learned: Be cognizant of sub levels and use them to add size or emergency lots.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-03-17 13:39:42 | MRNA | sell | $28.780 | short |
| 2020-03-17 13:39:50 | MRNA | sell | $28.890 | short |
| 2020-03-17 13:40:31 | MRNA | sell | $28.920 | short |
| 2020-03-17 13:41:16 | MRNA | sell | $29.040 | short |
| 2020-03-17 13:41:29 | MRNA | sell | $29.140 | short |
| 2020-03-17 13:42:08 | MRNA | buy | $28.870 | short |
| 2020-03-17 13:43:56 | MRNA | buy | $29.060 | short |
| 2020-03-17 13:44:48 | MRNA | buy | $29.130 | short |
| 2020-03-17 13:45:19 | MRNA | buy | $29.130 | short |
| 2020-03-17 13:45:58 | MRNA | buy | $29.120 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!